25-Hydroxyvitamin D levels and vitamin D deficiency in children with rheumatologic disorders and controls

Journal of Rheumatology

Volumn 38, Issue 9, 2011, Pages 2000-2004

  Pelajo, Christina F ^a   Lopez Benitez, Jorge M ^a,b   Miller, Laurie C ^a,b,c  

^a Floating Hospital for Children at Tufts Medical Center ^*  (United States)

^b TUFTS MEDICAL CENTER   (United States)

^c TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

25 Hydroxyvitamin D; Child; Rheumatology; Vitamin D deficiency

Indexed keywords

25 HYDROXYVITAMIN D; COLECALCIFEROL;

25 HYDROXYCOLECALCIFEROL BLOOD LEVEL; ADOLESCENT; ADULT; AGE; ARTICLE; AUTOIMMUNE DISEASE; BODY MASS; CHILD; CROSS-SECTIONAL STUDY; ETHNIC DIFFERENCE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; PRESCHOOL CHILD; PREVALENCE; PRIORITY JOURNAL; RHEUMATIC DISEASE; SCHOOL CHILD; SEASONAL VARIATION; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY; VITAMIN SUPPLEMENTATION;

EID: 80052338590     PISSN: 0315162X     EISSN: 14992752     Source Type: Journal    
DOI: 10.3899/jrheum.110123     Document Type: Article

References (43)

1. Arnson Y., Amital H., Shoenfeld Y. Vitamin D and autoimmunity:New aetiological and therapeutic considerations. Ann Rheum Dis 2007;66:1137-1142 (Pubitemid 47309727)
2. Van Halteren A.G., Tysma O.M., Van Etten E., Mathieu C., Roep B.O. 1-alpha,25-dihydroxyvitamin D3 or analogue treated dendritic cells modulate human autoreactive T cells via the selective induction of apoptosis. J Autoimmun 2004;23:233-239 (Pubitemid 40288105)
3. Cantorna M.T., Yu S., Bruce D. The paradoxical effects of vitamin D on type 1 mediated immunity. Mol Aspects Med 2008;29:369-375
4. Van Etten E., Mathieu C. Immunoregulation by 1,25-dihydroxyvitamin D3:Basic concepts. J Steroid Biochem Mol Biol 2005;97:93-101.
5. Holick M.F. Vitamin D deficiency. N Engl J Med 2007;357:266-281
6. Holick M.F. Vitamin D.: A millenium perspective. J Cell Biochem 2003;88:296-307.
7. Jirapongsananuruk O., Melamed I., Leung D.Y. Additive immunosuppressive effects of 1,25-dihydroxyvitamin D3 and corticosteroids on TH1, but not TH2, responses. J Allergy Clin Immunol 2000;106:981-985
8. Lemire J.M., Archer D.C., Beck L., Spiegelberg H.L. Immunosuppressive actions of 1,25-dihydroxyvitamin D3:Preferential inhibition of Th1 functions. J Nutr 1995;6 Suppl:1704S-1708S
9. Lemire J. 1,25- Dihydroxyvitamin D3- A hormone withimmunomodulatory properties. Z Rheumatol 2000;59 Suppl 1:24-27 (Pubitemid 30171413)
10. Chen S., Sims G.P., Chen X.X., Gu Y.Y., Lipsky P.E. Modulatory effectsof 1,25-dihydroxyvitamin D3 on human B cell differentiation.J Immunol 2007;179:1634-1647
11. Harel M., Shoenfeld Y. Predicting and preventing autoimmunity,myth or reality? Ann NY Acad Sci 2006;1069:322-345
12. Adorini L. Intervention in autoimmunity:The potential of vitamin Dreceptor agonists. Cell Immunol 2005;233:115-124 (Pubitemid 41074064)
13. Cantorna M.T. Vitamin D and autoimmunity:Is vitamin D status an environmental factor affecting autoimmune disease prevalence? Proc Soc Exp Biol Med 2000;223:230-233 (Pubitemid 30337776)
14. Andjelkovic Z., Vojinovic J., Pejnovic N., Popovic M., Dujic A., Mitrovic D., et al. Disease modifying and immunomodulatory effects of high dose 1 alpha (OH) D3 in rheumatoid arthritis patients. Clin Exp Rheumatol 1999;17:453-456 (Pubitemid 29343630)
15. Lemire J.M. Immunomodulatory actions of 1,25-dihydroxyvitamin D3. J Steroid Biochem Mol Biol 1995;53:599-602.
16. Orbach H., Zandman-Goddard G., Amital H., Barak V., Szekanecz Z., Szucs G., et al. Novel biomarkers in autoimmune diseases:Prolactin, ferritin, vitamin D, and TPA levels in autoimmune diseases. Ann NY Acad Sci 2007;1109:385-400. (Pubitemid 47511381)
17. Ruiz-Irastorza G., Egurbide M.V., Olivares N., Martinez-Berriotxoa A., Aguirre C. Vitamin D deficiency in systemic lupus erythematosus:Prevalence, predictors and clinical consequences. Rheumatology 2008;47:920-923 (Pubitemid 351796385)
18. Carvalho J.F. Anti-vitamin D, vitamin D in SLE. Ann NY Acad Sci 2007;1109:550-557
19. Becker A., Fischer R., Schneider M. [Bone density and 25-OH vitamin D serum level in patients with systemic lupus erythematosus]. Z Rheumatol 2001;60:352-358
20. Kamen D., Aranow C. Vitamin D in systemic lupus erythematosus. Curr Opin Rheumatol 2008;20:532-537
21. Holick M.F. Sunlight and vitamin D for bone health and prevention of autoimmune diseases, cancers, and cardiovascular disease. Am J Clin Nutr 2004;6 Suppl:1678S-1688S
22. Cannell J.J., Hollis B.W., Zasloff M., Heaney R.P. Diagnosis and treatment of vitamin D deficiency. Expert Opin Pharmacother 2008;9:107-118 (Pubitemid 351233752)
23. Shoenfeld N., Amital H., Shoenfeld Y. The effect of melanism and vitamin D synthesis on the incidence of autoimmune disease. Nat Clin Pract Rheumatol 2009;5:99-105.
24. Zittermann A. Vitamin D in preventive medicine:Are we ignoring the evidence? Br J Nutr 2003;89:552-572 (Pubitemid 36592083)
25. Cutolo M. Vitamin D and autoimmune rheumatic diseases. Rheumatology 2009;48:210-212
26. Muller K., Kriegbaum N.J., Baslund B., Sorensen O.H., Thymann M., Bentzen K. Vitamin D3 metabolism in patients with rheumatic diseases:Low serum levels of 25-hydroxyvitamin D3 in patients with systemic lupus erythematosus. Clin Rheumatol 1995;14:397-400.
27. Kamen D.L., Cooper G.S., Bouali H., Shaftman S.R., Hollis B.W., Gilkeson G.S. Vitamin D deficiency in systemic lupus erythematosus. Autoimmun Rev 2006;5:114-117 (Pubitemid 43129539)
28. Borba V.Z., Vieira J.G., Kasamatsu T., Radominski S.C., Sato E.I., Lazaretti-Castro M. Vitamin D deficiency in patients with active systemic lupus erythematosus. Osteoporos Int 2009;20:427-433
29. Wagner C.L., Greer F.R. Prevention of rickets and vitamin D deficiency in infants, children, and adolescents. Pediatrics 2008;122:1142-1152
30. Dong Y., Pollock N., Stallmann-Jorgensen I.S., Gutin B., Lan L., Chen T.C., et al. Low 25-hydroxyvitamin D levels in adolescents:Race, season, adiposity, physical activity, and fitness. Pediatrics 2010;125:1104-1111
31. Cole C.R., Grant F.K., Tangpricha V., Swaby-Ellis E.D., Smith J.L., Jacques A., et al. 25-hydroxyvitamin D status of healthy, low-income, minority children in Atlanta, Georgia. Pediatrics 2010;125:633-639
32. Update: prevalence of overweight among children, adolescents, and adults - United States, 1988- 1994. MMWR Morb Mortal Wkly Rep 1997;46:198-202.
33. Cutolo M., Otsa K., Laas K., Yprus M., Lehtme R., Secchi M.E., et al. Circannual vitamin D serum levels and disease activity in rheumatoid arthritis:Northern versus Southern Europe. Clin Exp Rheumatol 2006;24:702-704 (Pubitemid 46138805)
34. Patel S., Farragher T., Berry J., Bunn D., Silman A., Symmons D. Association between serum vitamin D metabolite levels and disease activity in patients with early inflammatory polyarthritis. Arthritis Rheum 2007;56:2143-2149 (Pubitemid 47173561)
35. Chiu G. Vitamin D deficiency among patients attending a central New Zealand rheumatology outpatient clinic. NZ Med J 2005;118:U1727.
36. Humbert P., Dupond J.L., Agache P., Laurent R., Rochefort A., Drobacheff C., et al. Treatment of scleroderma with oral 1,25-dihydroxyvitamin D3:Evaluation of skin involvement using non-invasive techniques. Results of an open prospective trial. Acta Derm Venereol 1993;73:449-451 (Pubitemid 23351347)
37. Reed A., Haugen M., Pachman L.M., Langman C.B. Abnormalities in serum osteocalcin values in children with chronic rheumatic diseases. J Pediatr 1990;116:574-580 (Pubitemid 20124154)
38. Hillman L., Cassidy J.T., Johnson L., Lee D., Allen S.H. Vitamin D metabolism and bone mineralization in children with juvenile rheumatoid arthritis. J Pediatr 1994;124:910-916 (Pubitemid 24184016)
39. Pepmueller P.H., Cassidy J.T., Allen S.H., Hillman L.S. Bone mineralization and bone mineral metabolism in children with juvenile rheumatoid arthritis. Arthritis Rheum 1996;39:746-757 (Pubitemid 26140419)
40. Bianchi M.L., Bardare M., Caraceni M.P., Cohen E., Falvella S., Borzani M., et al. Bone metabolism in juvenile rheumatoid arthritis. Bone Miner 1990;9:153-162 (Pubitemid 20150086)
41. Cutolo M., Otsa K., Paolino S., Yprus M., Veldi T., Seriolo B. Vitamin D involvement in rheumatoid arthritis and systemic lupus erythaematosus. Ann Rheum Dis 2009;68:446-447
42. Klein R.G., Arnaud S.B., Gallagher J.C., Deluca H.F., Riggs B.L. Intestinal calcium absorption in exogenous hypercortisonism. Role of 25-hydroxyvitamin D and corticosteroid dose. J Clin Invest 1977;60:253-259 (Pubitemid 8145163)
43. Do J.E., Kwon S.Y., Park S., Lee E.S. Effects of vitamin D on expression of Toll-like receptors of monocytes from patients with Behcet's disease. Rheumatology 2008;47:840-848 (Pubitemid 351796370)